Baillie Gifford & Co’s Insulet PODD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$311M Buy
2,042,313
+12,821
+0.6% +$2.14M 0.28% 76
2026
Q1
$426M Sell
2,029,492
-18,877
-0.9% -$4.74M 0.44% 49
2025
Q4
$582M Sell
2,048,369
-43,329
-2% -$13.5M 0.48% 45
2025
Q3
$646M Sell
2,091,698
-43,370
-2% -$13.6M 0.48% 42
2025
Q2
$671M Sell
2,135,068
-115,687
-5% -$33.4M 0.5% 37
2025
Q1
$591M Sell
2,250,755
-104,928
-4% -$28.4M 0.52% 41
2024
Q4
$615M Buy
2,355,683
+79,982
+4% +$20.1M 0.47% 45
2024
Q3
$530M Buy
2,275,701
+389,639
+21% +$80M 0.4% 52
2024
Q2
$381M Buy
1,886,062
+443,783
+31% +$80M 0.3% 67
2024
Q1
$247M Buy
1,442,279
+229,520
+19% +$42.8M 0.19% 91
2023
Q4
$263M Buy
+1,212,759
New +$208M 0.21% 89

Other funds holding PODD

Baillie Gifford & Co's PODD Position: Q2 2026 in Review

Baillie Gifford & Co increased its Insulet (PODD) stake by 0.63% in Q2 2026, buying an estimated $2.14M and bringing the position to 2,042,313 shares worth $311M. The position accounts for 0.28% of the portfolio, ranked #76.

Baillie Gifford & Co first reported a position in PODD in Q4 2023 and has held it in 11 quarters since. The position peaked at $671M in Q2 2025. 726 funds tracked by Wall St. Rank hold PODD as of Q2 2026.

  • Baillie Gifford & Co held 2,042,313 shares of Insulet worth $311M as of Q2 2026.
  • Baillie Gifford & Co bought 12,821 Insulet shares in Q2 2026, an estimated $2.14M.
  • Insulet made up 0.28% of Baillie Gifford & Co's portfolio in Q2 2026, its #76 holding.
  • Baillie Gifford & Co first reported a position in Insulet in Q4 2023 and has held it in 11 quarters since.
  • Baillie Gifford & Co's Insulet position peaked at $671M in Q2 2025.
  • 726 funds tracked by Wall St. Rank held Insulet as of Q2 2026.

Based on Baillie Gifford & Co's 13F filing for Q2 2026, filed 6 Aug 2026.